181 related articles for article (PubMed ID: 18221151)
41. HIV-1 integration as a target for antiretroviral therapy: a review.
Pluymers W; De Clercq E; Debyser Z
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):133-49. PubMed ID: 12455410
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity.
Di Santo R; Costi R; Artico M; Ragno R; Greco G; Novellino E; Marchand C; Pommier Y
Farmaco; 2005 May; 60(5):409-17. PubMed ID: 15910813
[TBL] [Abstract][Full Text] [Related]
43. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684
[TBL] [Abstract][Full Text] [Related]
44. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
[TBL] [Abstract][Full Text] [Related]
45. N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase.
Pescatori L; Métifiot M; Chung S; Masoaka T; Cuzzucoli Crucitti G; Messore A; Pupo G; Madia VN; Saccoliti F; Scipione L; Tortorella S; Di Leva FS; Cosconati S; Marinelli L; Novellino E; Le Grice SF; Pommier Y; Marchand C; Costi R; Di Santo R
J Med Chem; 2015 Jun; 58(11):4610-23. PubMed ID: 25961960
[TBL] [Abstract][Full Text] [Related]
46. Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors.
King PJ; Lee DJ; Reinke RA; Victoria JG; Beale K; Robinson WE
Virology; 2003 Feb; 306(1):147-61. PubMed ID: 12620807
[TBL] [Abstract][Full Text] [Related]
47. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
48. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase.
Li X; Vince R
Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908
[TBL] [Abstract][Full Text] [Related]
49. Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.
Kim JY; Kim EJ; Choi JY; Kwon OK; Kim GJ; Choi SY; Kim SS
Clin Microbiol Infect; 2011 Aug; 17(8):1155-9. PubMed ID: 20946407
[TBL] [Abstract][Full Text] [Related]
50. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes.
Zhang X; Marchand C; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2004 Mar; 14(5):1205-7. PubMed ID: 14980666
[TBL] [Abstract][Full Text] [Related]
52. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
Nair V
Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
[TBL] [Abstract][Full Text] [Related]
53. Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.
Bonnenfant S; Thomas CM; Vita C; Subra F; Deprez E; Zouhiri F; Desmaële D; D'Angelo J; Mouscadet JF; Leh H
J Virol; 2004 Jun; 78(11):5728-36. PubMed ID: 15140970
[TBL] [Abstract][Full Text] [Related]
54. HIV integrase: a target for AIDS therapeutics.
Thomas M; Brady L
Trends Biotechnol; 1997 May; 15(5):167-72. PubMed ID: 9161051
[TBL] [Abstract][Full Text] [Related]
55. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
Long YQ; Jiang XH; Dayam R; Sanchez T; Shoemaker R; Sei S; Neamati N
J Med Chem; 2004 May; 47(10):2561-73. PubMed ID: 15115398
[TBL] [Abstract][Full Text] [Related]
56. New first and second generation inhibitors of human immunodeficiency virus-1 integrase.
Pendri A; Meanwell NA; Peese KM; Walker MA
Expert Opin Ther Pat; 2011 Aug; 21(8):1173-89. PubMed ID: 21599420
[TBL] [Abstract][Full Text] [Related]
57. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
Cox AG; Nair V
Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
[TBL] [Abstract][Full Text] [Related]
58. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.
Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V
J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681
[TBL] [Abstract][Full Text] [Related]
59. Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
Pais GC; Zhang X; Marchand C; Neamati N; Cowansage K; Svarovskaia ES; Pathak VK; Tang Y; Nicklaus M; Pommier Y; Burke TR
J Med Chem; 2002 Jul; 45(15):3184-94. PubMed ID: 12109903
[TBL] [Abstract][Full Text] [Related]
60. The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
Buzón MJ; Dalmau J; Puertas MC; Puig J; Clotet B; Martinez-Picado J
AIDS; 2010 Jan; 24(1):17-25. PubMed ID: 19770695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
